uPAR is a critical vascular target, similar to VEGFR, because of its expression in both cultured endothelial vascular cells and tumor cells, which allows the targeting of existing tumor microenvironments and the inhibition of further angiogenesis and tumor growth [32]. Here, KDR is linked to neoplasm.